The drug of choice for many patients with relapsing-remitting multiple sclerosis (RRMS) is generally considered to be interferon beta.
Interferon Beta as a First-Line Treatment
According to experts, due to the strength of the evidence supporting its use, interferon beta is often the first-line treatment option for individuals diagnosed with relapsing-remitting multiple sclerosis.
- Robust Evidence: Interferon beta is backed by significant research demonstrating its effectiveness.
Considerations Regarding Interferon Beta Treatment
While interferon beta is a common initial treatment, it's important to note that several aspects of its use remain under investigation. These unresolved issues might impact treatment decisions and patient outcomes.
